{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T04:45:46Z","timestamp":1781757946180,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113986","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T22:25:23Z","timestamp":1636669523000},"page":"113986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Synthesis, biological, and structural explorations of a series of \u03bc-opioid receptor (MOR) agonists with high G protein signaling bias"],"prefix":"10.1016","volume":"228","author":[{"given":"Yifei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1639-0405","authenticated-orcid":false,"given":"Yonghai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aixia","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanglin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9516-577X","authenticated-orcid":false,"given":"Wentao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Cen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwei","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113986_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.mehy.2018.02.033","article-title":"Role of Apolipoprotein E in the tangled mystery of pain","volume":"114","author":"Dhillon","year":"2018","journal-title":"Med. Hypotheses"},{"issue":"8","key":"10.1016\/j.ejmech.2021.113986_bib2","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nrd3226","article-title":"Pain market","volume":"9","author":"Melnikova","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"14","key":"10.1016\/j.ejmech.2021.113986_bib3","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1111\/bph.13873","article-title":"The dynamic interaction between pain and opioid misuse","volume":"175","author":"Wilson-Poe","year":"2018","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejmech.2021.113986_bib4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s43440-021-00251-1","article-title":"Influence of G protein-biased agonists of \u03bc-opioid receptor on addiction-related behaviors","volume":"73","author":"Kudla","year":"2021","journal-title":"Pharmacol. Rep."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113986_bib5","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1007\/s00213-020-05638-1","article-title":"Behavioral effects of benzylideneoxymorphone (BOM), a low efficacy \u03bc opioid receptor agonist and a \u03b4 opioid receptor antagonist","volume":"237","author":"Mada","year":"2020","journal-title":"Psychopharmacology (Berl)"},{"issue":"10","key":"10.1016\/j.ejmech.2021.113986_bib6","doi-asserted-by":"crossref","first-page":"E1825","DOI":"10.1073\/pnas.1621433114","article-title":"Inhibition of \u03b19\u03b110 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain","volume":"114","author":"Romero","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113986_bib7","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0165-6147(98)01279-6","article-title":"Opioids: first lessons from knockout mice","volume":"20","author":"Kieffer","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113986_bib8","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00000542-200105000-00021","article-title":"Anesthetic potency and influence of morphine and sevoflurane on respiration in mu-opioid receptor knockout mice","volume":"94","author":"Dahan","year":"2001","journal-title":"Anesthesiology"},{"issue":"6","key":"10.1016\/j.ejmech.2021.113986_bib9","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/bja\/aen094","article-title":"Opioids and the control of respiration","volume":"100","author":"Pattinson","year":"2008","journal-title":"Br. J. Anaesth."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113986_bib10","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/ALN.0000000000002184","article-title":"Averting opioid-induced respiratory depression without affecting analgesia","volume":"128","author":"Dahan","year":"2018","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2021.113986_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuropharm.2019.02.008","article-title":"Respiratory depression and brain hypoxia induced by opioid drugs: morphine, oxycodone, heroin, and fentanyl","volume":"151","author":"Kiyatkin","year":"2019","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.ejmech.2021.113986_bib12","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41580-018-0049-3","article-title":"Mechanisms of signalling and biased agonism in G protein-coupled receptors","volume":"19","author":"Wootten","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113986_bib13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s41386-019-0491-8","article-title":"A\u00a0G protein signaling-biased agonist at the \u03bc-opioid receptor reverses morphine tolerance while preventing morphine withdrawal","volume":"45","author":"Grim","year":"2020","journal-title":"Neuropsychopharmacology"},{"issue":"1","key":"10.1016\/j.ejmech.2021.113986_bib14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/s41467-017-02008-y","article-title":"Insight into partial agonism by observing multiple equilibria for ligand-bound and G(s)-mimetic nanobody-bound \u03b2(1)-adrenergic receptor","volume":"8","author":"Solt","year":"2017","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113986_bib15","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/s41422-019-0256-2","article-title":"A\u00a0complex structure of arrestin-2 bound to a G protein-coupled receptor","volume":"29","author":"Yin","year":"2019","journal-title":"Cell Res."},{"key":"10.1016\/j.ejmech.2021.113986_bib16","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.44502","article-title":"Nedd4 E3 ligase and beta-arrestins regulate ubiquitination, trafficking, and stability of the mGlu7 receptor","volume":"8","author":"Lee","year":"2019","journal-title":"Elife"},{"key":"10.1016\/j.ejmech.2021.113986_bib17","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.23777","article-title":"Phosphorylation of \u03b2-arrestin2 at Thr(383) by MEK underlies \u03b2-arrestin-dependent activation of Erk1\/2 by GPCRs","volume":"6","author":"Cassier","year":"2017","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113986_bib18","doi-asserted-by":"crossref","first-page":"E587","DOI":"10.1208\/aapsj070360","article-title":"Mu opioid receptor regulation and opiate responsiveness","volume":"7","author":"Raehal","year":"2005","journal-title":"AAPS J."},{"issue":"13","key":"10.1016\/j.ejmech.2021.113986_bib19","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/bph.13801","article-title":"Biased agonism and allosteric modulation of G protein-coupled receptor 183 - a 7TM receptor also known as Epstein-Barr virus-induced gene 2","volume":"174","author":"Daugvilaite","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113986_bib20","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/978-3-642-41199-1_22","article-title":"\u03b2-arrestins: regulatory role and therapeutic potential in opioid and cannabinoid receptor-mediated analgesia","volume":"219","author":"Raehal","year":"2014","journal-title":"Handb. Exp. Pharmacol."},{"issue":"5449","key":"10.1016\/j.ejmech.2021.113986_bib21","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1126\/science.286.5449.2495","article-title":"Enhanced morphine analgesia in mice lacking beta-arrestin 2","volume":"286","author":"Bohn","year":"1999","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113986_bib22","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1124\/jpet.105.087254","article-title":"Morphine side effects in beta-arrestin 2 knockout mice","volume":"314","author":"Raehal","year":"2005","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"7619","key":"10.1016\/j.ejmech.2021.113986_bib23","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.ejmech.2021.113986_bib24","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1124\/jpet.112.201616","article-title":"A\u00a0G protein-biased ligand at the \u03bc-opioid receptor is potently analgesic with reduced gastrointestinal and respiratory dysfunction compared with morphine","volume":"344","author":"DeWire","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"20","key":"10.1016\/j.ejmech.2021.113986_bib25","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1021\/jm4010829","article-title":"Structure-activity relationships and discovery of a G protein biased \u03bc opioid receptor ligand, [(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro-[4.5]decan-9-yl]ethyl})amine (TRV130), for the treatment of acute severe pain","volume":"56","author":"Chen","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2021.113986_bib26","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.cell.2017.10.035","article-title":"Bias factor and therapeutic window correlate to predict safer opioid analgesics","volume":"171","author":"Schmid","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ejmech.2021.113986_bib27","doi-asserted-by":"crossref","first-page":"9261","DOI":"10.1021\/acsomega.7b01452","article-title":"Discovery of SHR9352: a highly potent G protein-biased \u03bc-opioid receptor agonist","volume":"2","author":"Li","year":"2017","journal-title":"ACS Omega"},{"issue":"13","key":"10.1016\/j.ejmech.2021.113986_bib28","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1111\/bph.15004","article-title":"Morphine-induced respiratory depression is independent of \u03b2-arrestin2 signalling","volume":"177","author":"Kliewer","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113986_bib29","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.2147\/JPR.S137952","article-title":"A\u00a0randomized, Phase IIb study investigating oliceridine (TRV130), a novel \u03bc-receptor G-protein pathway selective (\u03bc-GPS) modulator, for the management of moderate to severe acute pain following abdominoplasty","volume":"10","author":"Singla","year":"2017","journal-title":"J.\u00a0Pain Res."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113986_bib30","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.pain.2014.06.011","article-title":"Biased agonism of the \u03bc-opioid receptor by TRV130 increases analgesia and reduces on-target adverse effects versus morphine: a randomized, double-blind, placebo-controlled, crossover study in healthy volunteers","volume":"155","author":"Soergel","year":"2014","journal-title":"Pain"},{"issue":"17","key":"10.1016\/j.ejmech.2021.113986_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25173870","article-title":"Biased versus partial agonism in the search for safer opioid analgesics","volume":"25","author":"Azevedo Neto","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113986_bib32","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3762\/bjoc.8.19","article-title":"Efficient, highly diastereoselective MS 4 \u00c5-promoted one-pot, three-component synthesis of 2,6-disubstituted-4-tosyloxytetrahydropyrans via Prins cyclization","volume":"8","author":"Ahmed","year":"2012","journal-title":"Beilstein J. Org. Chem."},{"issue":"7565","key":"10.1016\/j.ejmech.2021.113986_bib33","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nature14886","article-title":"Structural insights into \u03bc-opioid receptor activation","volume":"524","author":"Huang","year":"2015","journal-title":"Nature"},{"issue":"14","key":"10.1016\/j.ejmech.2021.113986_bib34","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.1021\/acs.jmedchem.0c00503","article-title":"Synthesis and structure-activity relationships of 5'-Aryl-14-alkoxypyridomorphinans: identification of a \u03bc opioid receptor agonist\/\u03b4 opioid receptor antagonist ligand with systemic antinociceptive activity and diminished opioid side effects","volume":"63","author":"Vekariya","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2021.113986_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1021\/acschemneuro.0c00487","article-title":"Design, synthesis, and structure-activity relationship exploration of Alkyl\/phenylalkyl piperidine analogues as novel highly potent and selective \u03bc opioid receptor agonists","volume":"12","author":"Huang","year":"2021","journal-title":"ACS Chem. Neurosci."},{"issue":"9","key":"10.1016\/j.ejmech.2021.113986_bib36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.4155\/fmc-2016-0232","article-title":"Fluorescent-labeled bioconjugates of the opioid peptides biphalin and DPDPE incorporating fluorescein-maleimide linkers","volume":"9","author":"Stefanucci","year":"2017","journal-title":"Future Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2021.113986_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12929-014-0062-6","article-title":"Isobolographic analysis of the opioid-opioid interactions in a tonic and a phasic mouse model of induced nociceptive pain","volume":"21","author":"Miranda","year":"2014","journal-title":"J.\u00a0Biomed. Sci."},{"issue":"12","key":"10.1016\/j.ejmech.2021.113986_bib38","first-page":"1781","article-title":"Synthetic Studies of Neoclerodane Diterpenes from Salvia Divinorum: Design, Synthesis, and Evaluation of Analogues with Improved Potency and G-Protein Activation Bias at the \u03bc-Opioid Receptor","volume":"11","author":"Crowley","year":"2020"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421008357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:37:24Z","timestamp":1759329444000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421008357"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":38,"alternative-id":["S0223523421008357"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113986","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, biological, and structural explorations of a series of \u03bc-opioid receptor (MOR) agonists with high G protein signaling bias","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113986"}}